Vivos Therapeutics prices $4.3M registered direct offering of 1,363,812 shares at $3.15/share

Vivos Therapeutics, Inc.

Gross proceeds of ~$4.3M before fees; closing expected Sept 20, 2024.
Placement agent H.C. Wainwright receives 7% cash fee plus 95,467 warrants at $3.9375.
Net proceeds to be used for working capital and general corporate purposes.
No warrants issued to investors; offering priced at-the-market under Nasdaq rules.
Shares sold under effective shelf registration statement (File No. 333-262554).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.